enVVeno Medical Corp (NVNO) Stock Price, Financials & Summary

Price chart

Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19

Key dataOct 19, 2026

Open$7.78

From 52W high−71.95%

Volume33205.00

Market cap$5.34M

P/E (TTM)—

P/S (TTM)—

Div yield—

Key dataOct 19, 2026

Open

$7.78

From 52W high

−71.95%

Volume

33205.00

Market cap

$5.34M

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

1.0x

P/E (TTM)

—

RSI (14)

39.2

MomentumView details →

1D Return

+2.95%

YTD Return

−32.72%

SummaryUpdated Jun 1, 2026

enVVeno Medical Corporation (NASDAQ:NVNO) is a medical device company founded in 1999 and based in Irvine, California. Originally incorporated as Hancock Jaffe Laboratories, Inc., the company rebranded to enVVeno Medical Corporation in October 2021 to better reflect its focus on venous disease treatment solutions. The company went public in May 2018 and specializes in developing bioprosthetic tissue-based medical devices designed to improve treatment standards for patients suffering from venous diseases.

Ask drillr about enVVeno Medical Corp →

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

1.0x

EV/Sales

—

P/S (TTM)

—

P/B (TTM)

0.3x

ProfitabilityView details →

Gross Margin

—

Net Margin

—

EBITDA Margin

—

ROE (TTM)

−76.07%

ROA (TTM)

−69.39%

Asset Turnover

0.00x

GrowthView details →

Revenue YoY

—

EPS YoY

+64.91%

FCF YoY

+14.65%

Revenue CAGR 3Y

—

EPS CAGR 3Y

+97.87%

EBITDA YoY

+31.10%

MomentumView details →

1D Return

+2.95%

YTD Return

−32.72%

1Y Return

−72.03%

RSI (14)

39.2

vs 50D SMA

−20.62%

vs 200D SMA

−27.30%

Capital & dividendView details →

Debt/Equity

0.02x

Current Ratio

11.70x

Quick Ratio

11.70x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

−$5.37

EPS Surprise

−14.50%

Beats (12Q)

7/12

Next Q EPS Est

−$2.35

Avg Surprise (4Q)

7.77%

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

0.00

Net Income (TTM)

−15.72M

Op. CF (TTM)

−14.62M

Next earningsOct 30, 2026 →

Latest newsMore news →

enVVeno Medical Corporation announced it will present its investigational enVVe System at The VEINS 2026 innovation summit in Las Vegas, Nevada.17d ago

ENVVENO MEDICAL CORP filed a mixed shelf registration statement to offer up to $100 million in securities.59d ago

Similar companies

Autonomix Medical, Inc. Common StockAMIX Pheton Holdings Ltd Class A Ordinary SharesPTHL Bone Biologics CorporationBBLGW Inspira Technologies Oxy B.H.N. Ltd.IINNW IceCure Medical LtdICCM Biomerica, Inc.BMRA Find similar companies →

Latest newsMore news →

enVVeno Medical Corporation announced it will present its investigational enVVe System at The VEINS 2026 innovation summit in Las Vegas, Nevada.17d ago ENVVENO MEDICAL CORP filed a mixed shelf registration statement to offer up to $100 million in securities.59d ago